Commonwealth Equity Services’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-4,919
| Closed | -$289K | – | 4040 |
|
|
2024
Q1 | $289K | Sell |
4,919
-2,249
| -31% | -$132K | ﹤0.01% | 3312 |
|
|
2023
Q4 | $429K | Buy |
7,168
+246
| +4% | +$14.7K | ﹤0.01% | 2860 |
|
|
2023
Q3 | $263K | Buy |
6,922
+2,263
| +49% | +$86K | ﹤0.01% | 3146 |
|
|
2023
Q2 | $424K | Sell |
4,659
-736
| -14% | -$67K | ﹤0.01% | 2758 |
|
|
2023
Q1 | $355 | Buy |
+5,395
| New | +$355 | ﹤0.01% | 2825 |
|